InChI=1S/C23H28F2N6O4S/c1- 2- 7- 36- 23- 27- 21(26- 15- 9- 12(15) 11- 3- 4- 13(24) 14(25) 8- 11) 18- 22(28- 23) 31(30- 29- 18) 16- 10- 17(35- 6- 5- 32) 20(34) 19(16) 33/h3- 4,8,12,15- 17,19- 20,32- 34H,2,5- 7,9- 10H2,1H3,(H,26,27,28) /t12- ,15+,16+,17- ,19- ,20+/m0/s1 |
OEKWJQXRCDYSHL-FNOIDJSQSA-N |
CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@@H]3C[C@H](OCCO)[C@@H](O)[C@H]3O)c2n1 |
|
Bronsted base
A molecular entity capable of accepting a hydron from a donor (Bronsted acid).
(via organic amino compound )
|
|
P2Y12 receptor antagonist
An antagonist at the P2Y12 receptor
|
|
platelet aggregation inhibitor
A drug or agent which antagonizes or impairs any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system.
|
|
View more via ChEBI Ontology
(1S,2S,3R,5S)- 3- [7- {[(1R,2S)- 2- (3,4- difluorophenyl)cyclopropyl]amino}- 5- (propylsulfanyl)- 3H- [1,2,3]triazolo[4,5- d]pyrimidin- 3- yl]- 5- (2- hydroxyethoxy)cyclopentane- 1,2- diol
|
(1S,2S,3R,5S)- 3- (7- ((1R,2S)- 2- (3,4- Difluorophenyl)cyclopropylamino)- 5- (propylthio)- 3H- (1,2,3)triazolo(4,5- d)pyrimidin- 3- yl)- 5- (2- hydroxyethoxy)cyclopentane- 1,2- diol
|
ChemIDplus
|
AZD 6140
|
ChemIDplus
|
AZD-6140
|
ChemIDplus
|
AZD6140
|
ChemIDplus
|
15468079
|
Reaxys Registry Number
|
Reaxys
|
274693-27-5
|
CAS Registry Number
|
ChemIDplus
|
22991347
|
PubMed citation
|
Europe PMC
|
|